Evana Heavy Period Relief Tranexamic Acid 500mg 18 Tablets
Evana Heavy Period Relief Tranexamic Acid 500mg 18 Tablets
What 500,000+ customers say about medino:
Description
Evana Heavy Period Relief offers non-hormonal help for regular and heavy periods. It contains tranexamic acid, which reduces blood loss. Evana is simple to use and improves daily life.
Key Features
- Non-hormonal: Does not change hormones or affect fertility.
- Convenient: Only take it on heavy bleeding days.
- Over-the-counter: No doctor’s prescription is required.
- Quality of life: Aids return to daily activities.
Uses
- Heavy periods: Eases excessive menstrual blood loss.
- Flooding: Helps prevent leaks on clothes or bedding.
- Frequent changes: Reduces need for pads or tampons often.
- Daily life: Supports regular routines during periods.
- Anaemia help: May lower the chance of low iron levels.
- Quality of life: Makes social and leisure time better.
How does Evana Heavy Period Relief work?
Evana contains tranexamic acid, which supports blood clotting. It slows clot breakdown in the womb, lowering blood loss.
What research has been published regarding Evana Heavy Period Relief's key ingredients?
Studies confirm tranexamic acid’s effectiveness for reducing blood loss. A large 2001 study showed better life quality for over 800 women. Other trials back its safety and results.
What do customers say about Evana Heavy Period Relief?
Users often see less bleeding during their first cycle. Many feel more normal and comfortable while using it. Some report mild side effects like nausea.
How long does it take to see results?
Most women notice changes in the first cycle. Some might need up to three cycles. If no change occurs after three months, seek medical advice.
Are there any side effects?
Side effects are rare and mild. These include nausea, diarrhoea, or headaches. Stop use and consult a doctor if worried.
Ingredients
Each tablet contains:
- Active ingredient: 500 mg of tranexamic acid
- Other ingredients: Calcium hydrogen phosphate (anhydrous), croscarmellose sodium, povidone, talc, and magnesium stearate.
Usage and Instructions
- Take Evana only when your period has started and bleeding is heavy.
- Recommended dosage: 2 tablets, 3 times daily (morning, afternoon, evening) for up to 4 days.
- If bleeding doesn't improve, you can take an extra 2 tablets at night. Do not exceed 8 tablets (4g) in 24 hours.
- Typically, bleeding improves after 2 days. If that happens, reduce the dose to 2 tablets twice a day.
- Swallow tablets whole with water. Do not crush or chew.
- Do not use for more than 4 days during each period.
- Safe for long-term use if periods remain regular and heavy.
- Consult your doctor if bleeding is not reduced after three cycles.
Warnings
Do not take Evana if you:
- Are allergic to tranexamic acid or any listed ingredients.
- Are under 18 years old.
- Are pregnant.
- Have kidney problems.
- Have or have had a blood clot.
- Have a family history of blood clots.
- Have blood in your urine between periods.
- Have irregular periods.
- Are taking medicines to prevent or treat blood clots (e.g., warfarin).
- Are taking oral contraceptives.
- Have disseminated intravascular coagulation (DIC).
- Have a history of fits or seizures.
Consult your doctor before use if you:
- Are over 45 years old.
- Are diabetic.
- Are very overweight (obese).
- Have polycystic ovary syndrome (PCOS).
- Have a family history of endometrial cancer.
- Have noticed changes in your normal bleeding pattern.
- Experience abnormal bleeding between periods.
- Bleed after sexual intercourse.
- Have pain during sexual intercourse.
Stop taking and seek urgent medical attention if you experience:
- Chest pain or heaviness.
- Unusual pain or swelling in arms or legs.
- Sudden shortness of breath.
- Fainting.
- Coughing up blood.
Side Effects
Category | Frequency | Adverse Effects |
---|---|---|
Gastrointestinal discomfort | Most common | Discomfort, resolves when dosage reduced |
Immune system disorders | Very rare (<1/10,000) | Hypersensitivity reactions, including anaphylaxis |
Gastrointestinal disorders (4 g/day) | Common (≥1/100 to <1/10) | Nausea, vomiting, diarrhoea |
Skin & subcutaneous tissue disorders | Uncommon (≥1/1,000 to <1/100) | Allergic skin reactions |
Other adverse events | Frequency not estimable from available data | Thromboembolic events, retinal/artery occlusion, impaired colour vision or other visual disturbances, seizures (particularly in misuse) |
Reporting | — | Report suspected adverse reactions via the MHRA Yellow Card Scheme or via the MHRA Yellow Card app |